Harvard Bioscience, Inc. (HBIO) compared with its closest peers (CTKB, EYPT, PACB, QSI, QTRX). Peer set by Business model: Medical Devices / Life Science Tools; 10 closest by market cap; US-domiciled. First-party data.
| Company | Market Cap | P/E |
|---|---|---|
| Cytek Biosciences, Inc. (CTKB) | $605.07M | -9.7 |
| EyePoint Pharmaceuticals, Inc. (EYPT) | $466.41M | -5.8 |
| Pacific Biosciences of California, Inc. (PACB) | $380.77M | -1.0 |
| Quantum-Si incorporated (QSI) | $153.94M | -2.1 |
| Quanterix Corporation (QTRX) | $147.55M | -2.5 |
| Nautilus Biotechnology, Inc. (NAUT) | $114.35M | -4.1 |
| Seer, Inc. (SEER) | $111.85M | -1.4 |
| Rapid Micro Biosystems, Inc. (RPID) | $80.74M | -2.7 |
| Precipio, Inc. (PRPO) | $51.90M | -102.4 |
| Astrotech Corporation (ASTC) | $13.54M | -0.7 |
| Sector P/E (Technology) | 33.9 |
| Industry P/E (Measuring & Control Equipment) | 51.8 |
HBIO overview · HBIO earnings · HBIO financials · HBIO KPIs · HBIO investor relations · HBIO ownership · HBIO filings
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.